Stomach Pain on Wegovy: What's Normal, What's Not, and When to Act

Stomach pain is one of the most frequently reported side effects of semaglutide, particularly during the early weeks and at each dose step.
Slowed gastric emptying is the main mechanism: Wegovy reduces how fast food moves through your stomach, which can cause pressure, cramping and nausea alongside the discomfort.
Severe or persistent pain, especially if it radiates toward the back, needs urgent medical attention — it can signal acute pancreatitis, a rare but serious side effect flagged by the MHRA.
Most mild stomach pain can be reduced by eating smaller meals, avoiding fatty or rich foods, and eating slowly — practical steps covered on our guide to managing Wegovy stomach pain.

Stomach pain on Wegovy is very common, particularly in the first few weeks of treatment or after a dose increase. It usually arrives as cramping, bloating or a dull ache in the upper abdomen, driven by the way semaglutide slows how quickly food leaves the stomach. For most people, the discomfort is mild and settles within days. It can feel unsettling, but that doesn't make it dangerous. Wegovy is a prescription-only medicine, and any persistent or severe stomach pain should be discussed with your prescriber, who can help you work out what's causing it and whether anything needs to change.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A step-by-step look at Wegovy stomach pain: why it happens, what to expect, and the warning signs that matter

Step 1: Understanding why Wegovy causes stomach pain in the first place

Semaglutide works by activating GLP-1 receptors in the gut and brain. One of its direct effects is slowing gastric emptying, the rate at which your stomach pushes food into the small intestine. That slowdown is part of why Wegovy reduces appetite so effectively. It also explains why stomach pain, bloating and nausea tend to cluster together: when food lingers longer than usual, pressure builds, and the stomach's muscular walls respond with cramping.

On top of that, semaglutide affects gut motility more broadly, which is why some people on Wegovy also notice loose stools, constipation or both at different points in treatment. If you want a clearer picture of the underlying mechanism, the semaglutide overview on our site explains how the medicine works and what the clinical evidence shows.

The NHS medicines page for semaglutide lists abdominal pain among the common side effects, alongside nausea, vomiting, diarrhoea and constipation. Common in this context means it affects roughly one in ten people or more. In practice, many patients experience at least one of these GI effects at some point, particularly in the opening weeks of treatment or around dose changes. Knowing that in advance makes it easier to ride it out rather than panic at the first twinge. That said, not every stomach ache during treatment is caused by the medicine, and severity matters enormously. The next two steps cover both.

For broader context on how Wegovy is used in the UK (including eligibility and how it fits into a structured weight management plan) the Wegovy treatment page is a good starting point.

Step 2: What the stomach pain typically feels like, and how long it usually lasts

The pattern most people describe is a crampy, sometimes bloated ache around the upper abdomen. It can come on during a meal if you've eaten too quickly or too much, or linger for an hour or two afterwards. Some people describe it as pressure; others as an unsettled, queasy heaviness. Injection-site discomfort sits separately from this and should not be confused with internal abdominal pain, if you're unsure where Wegovy is actually injected and what's normal at the site, the page on Wegovy injections in the stomach area covers that clearly.

In terms of timing, stomach pain on Wegovy tends to be worst in the days immediately after a new pen or a dose increase. The 0.25mg starting dose is the tolerability step, the one that's there to let your body adjust before the therapeutic doses begin. Most people find discomfort peaks somewhere in that first week and then gradually softens. By week three or four at a given dose level, the gut has usually adapted enough that meals feel normal again, at least until the next dose step.

A small number of people find that eating anything rich, fatty or in large portions reliably triggers cramping throughout their time on treatment. Eating the way most of us manage on a busy Tuesday (too fast, too much, standing over the hob) makes things noticeably worse. Slowing down and halving portions is often more effective than any supplement.

You can read about stomach pains on Wegovy in more depth, including how the experience changes across different dose levels.

Step 3: The warning signs that mean you need medical help, not a wait-and-see approach

Most Wegovy-related stomach pain is mild and self-limiting. Some is not, and it matters to know the difference before it escalates.

In January 2026, the MHRA published a Drug Safety Update specifically on GLP-1 receptor agonist medicines, highlighting acute pancreatitis as an infrequent but potentially serious risk. The symptom to act on immediately is severe, persistent pain in the upper abdomen that spreads toward the back, it may or may not come with vomiting. If that describes what you're feeling, stop eating and drinking and get urgent medical help rather than waiting for your next prescriber review. This is the scenario that changes the equation from "expected side effect" to "requires same-day assessment".

Other symptoms that warrant a prompt call to your GP or prescriber include pain accompanied by signs of dehydration (dark urine, dizziness, inability to keep fluids down for more than a few hours) or sudden worsening of pain that doesn't match the usual post-meal pattern. You can also report unexpected side effects directly through the MHRA Yellow Card scheme, which helps regulators monitor the safety of medicines in real-world use.

Semaglutide-related stomach pain relief, including which foods and habits genuinely help, is covered on our dedicated semaglutide stomach pain relief page. And if your symptoms feel more like a sudden gastric illness than the usual adjustment period, the comparison on our Wegovy stomach flu page may help you tell the two apart.

If you're already on Wegovy and finding side effects hard to manage, reaching out to your prescriber is always the right move. For those earlier in the process who are considering treatment and want to understand what supervised, clinically reviewed care looks like, checking your eligibility with our prescribers costs nothing and takes a few minutes.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions